News GSK's CEO Walmsley aiming for six new approvals in 2020 GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year.
News Astellas to work with Adaptimmune to develop 'off the shelf'... Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer.
News Experts call for review of innovative cancer therapies to bo... There should be an independent review of how advances in cancer treatment are valued and paid for by the NHS and healthcare providers, according to a new policy report calling for improveme
News Blueprint gets first approval as FDA backs stomach cancer dr... US biotech Blueprint Medicines has its first approved drug, after the FDA backed its oncology drug Ayvakit for a certain kind of stomach cancer.
News Merck partners Remepy in PDURS-focused alliance Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
